| scholarly article | Q13442814 |
| P2093 | author name string | E S Mocarski | |
| J M Cherrington | |||
| G W Wilkinson | |||
| L C Sambucetti | |||
| P2860 | cites work | 56 RNA polymerase nascent product analysis | Q72608453 |
| Multiple nuclear factors interact with the immunoglobulin enhancer sequences | Q24296245 | ||
| I kappa B: a specific inhibitor of the NF-kappa B transcription factor | Q24296774 | ||
| Characterization of antigen receptor response elements within the interleukin-2 enhancer | Q24632042 | ||
| Equilibria and kinetics of lac repressor-operator interactions by polyacrylamide gel electrophoresis | Q24633932 | ||
| Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei | Q27860728 | ||
| Functional dissection of a eukaryotic transcriptional activator protein, GCN4 of yeast | Q27933378 | ||
| Temporal Patterns of Human Cytomegalovirus Transcription: Mapping the Viral RNAs Synthesized at Immediate Early, Early, and Late Times After Infection | Q28264539 | ||
| Activation of transcription by two factors that bind promoter and enhancer sequences of the human metallothionein gene and SV40 | Q28288094 | ||
| Activation of DNA-binding activity in an apparently cytoplasmic precursor of the NF-kappa B transcription factor | Q28615489 | ||
| An inducible transcription factor activates expression of human immunodeficiency virus in T cells | Q29618434 | ||
| Inducibility of kappa immunoglobulin enhancer-binding protein Nf-kappa B by a posttranslational mechanism | Q29619866 | ||
| NF-kappa B: a pleiotropic mediator of inducible and tissue-specific gene control | Q29620172 | ||
| Transcription activation by the adenovirus E1a protein | Q29620538 | ||
| Deletion analysis of GAL4 defines two transcriptional activating segments | Q29620547 | ||
| Double-stranded RNA activates binding of NF-kappa B to an inducible element in the human beta-interferon promoter | Q33562993 | ||
| T-cell-specific expression of interleukin 2: evidence for a negative regulatory site | Q33569344 | ||
| Hepatitis B virus X gene can transactivate heterologous viral sequences | Q33845263 | ||
| Nuclear factor 1 interacts with five DNA elements in the promoter region of the human cytomegalovirus major immediate early gene | Q33879942 | ||
| Trans-acting transcriptional activation of the long terminal repeat of human T lymphotropic viruses in infected cells | Q34255923 | ||
| Functional dissection of VP16, the trans-activator of herpes simplex virus immediate early gene expression | Q34555693 | ||
| Binding of transcription factors and creation of a large nucleoprotein complex on the human cytomegalovirus enhancer | Q34626976 | ||
| A labile inhibitor blocks immunoglobulin kappa-light-chain-gene transcription in a pre-B leukemic cell line | Q35585717 | ||
| Promoter-regulatory region of the major immediate early gene of human cytomegalovirus | Q36252923 | ||
| Human cytomegalovirus replicates in primary human bone marrow cells | Q36426056 | ||
| Human cytomegalovirus ie1 transactivates the alpha promoter-enhancer via an 18-base-pair repeat element. | Q36781988 | ||
| Binding of a nuclear factor to a regulatory sequence in the promoter of the mouse H-2Kb class I major histocompatibility gene | Q36833546 | ||
| Adenovirus 5 early region 1A host range mutants hr3, hr4, and hr5 contain point mutations which generate single amino acid substitutions. | Q36850906 | ||
| Regulation of cytomegalovirus gene expression: alpha and beta promoters are trans activated by viral functions in permissive human fibroblasts | Q36851094 | ||
| trans-activation and autoregulation of gene expression by the immediate-early region 2 gene products of human cytomegalovirus | Q36865895 | ||
| Specific interactions between transcription factors and the promoter-regulatory region of the human cytomegalovirus major immediate-early gene | Q36876976 | ||
| Multiple tandemly repeated binding sites for cellular nuclear factor 1 that surround the major immediate-early promoters of simian and human cytomegalovirus | Q36887668 | ||
| Activation of the major immediate early gene of human cytomegalovirus by cis-acting elements in the promoter-regulatory sequence and by virus-specific trans-acting components | Q36903371 | ||
| Structural analysis of the major immediate early gene of human cytomegalovirus | Q36911017 | ||
| Identification of a cyclic-AMP-responsive element within the rat somatostatin gene | Q37398428 | ||
| Two transcription factors, NF-kappa B and H2TF1, interact with a single regulatory sequence in the class I major histocompatibility complex promoter | Q37485004 | ||
| Cytomegalovirus infects human lymphocytes and monocytes: virus expression is restricted to immediate-early gene products | Q37571081 | ||
| Sequence of protein synthesis in cells infected by human cytomegalovirus: early and late virus-induced polypeptides | Q37601559 | ||
| HTLV-I tax induces cellular proteins that activate the kappa B element in the IL-2 receptor alpha gene | Q38346482 | ||
| Footprinting DNA-protein complexes in situ following gel retardation assays using 1,10-phenanthroline-copper ion: Escherichia coli RNA polymerase-lac promoter complexes | Q38348378 | ||
| Immediate early antigens in human cytomegalovirus infected cells | Q40119555 | ||
| Replication of human cytomegalovirus in human peripheral blood T cells | Q40131126 | ||
| Induction of Pre-Early Nuclear Antigen(s) in HEL Cells Infected with Human Cytomegalovirus | Q40247083 | ||
| The role of the kappa enhancer and its binding factor NF-kappa B in the developmental regulation of kappa gene transcription | Q43814141 | ||
| Immunoglobulin gene transcription is activated by downstream sequence elements | Q43904180 | ||
| The involvement of NF-kappa B in beta-interferon gene regulation reveals its role as widely inducible mediator of signal transduction | Q44684470 | ||
| Expression of the acidic nuclear immediate-early protein (IE1) of human cytomegalovirus in stable cell lines and its preferential association with metaphase chromosomes | Q44878740 | ||
| A trans-acting factor is responsible for the simian virus 40 enhancer activity in vitro | Q45839074 | ||
| A cis-acting element within the 5' leader of a cytomegalovirus beta transcript determines kinetic class | Q48359930 | ||
| A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus | Q48378635 | ||
| The structure of the major immediate early gene of human cytomegalovirus strain AD169. | Q48381043 | ||
| Functional domains of adenovirus type 5 E1a proteins. | Q53527275 | ||
| Cellular transcription factors and regulation of IL-2 receptor gene expression by HTLV-I tax gene product. | Q55242465 | ||
| HTLV-1 transactivator induces interleukin-2 receptor expression through an NF-kappa B-like factor. | Q55242466 | ||
| A family of immunologically related transcription factors that includes multiple forms of ATF and AP-1 | Q64379444 | ||
| Detection of human cytomegalovirus in peripheral blood lymphocytes in a natural infection | Q70107755 | ||
| Protein counterparts of human and simian cytomegaloviruses | Q70161702 | ||
| Protein-binding sites in Ig gene enhancers determine transcriptional activity and inducibility | Q70343054 | ||
| P433 | issue | 13 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | NF-κB | Q411114 |
| Cytomegalovirus | Q6946 | ||
| P304 | page(s) | 4251-4258 | |
| P577 | publication date | 1989-12-01 | |
| P1433 | published in | The EMBO Journal | Q1278554 |
| P1476 | title | NF-kappa B activation of the cytomegalovirus enhancer is mediated by a viral transactivator and by T cell stimulation | |
| P478 | volume | 8 |
| Q40064469 | A 10-base-pair element of the human immunodeficiency virus type 1 long terminal repeat (LTR) is an absolute requirement for transactivation by the human cytomegalovirus 72-kilodalton IE1 protein but can be compensated for by other LTR regions in tra |
| Q37248409 | A deletion mutant in the human cytomegalovirus gene encoding IE1(491aa) is replication defective due to a failure in autoregulation |
| Q40115668 | A discrete cis element in the human immunodeficiency virus long terminal repeat mediates synergistic trans activation by cytomegalovirus immediate-early proteins |
| Q39794074 | A doubly fluorescent HIV-1 reporter shows that the majority of integrated HIV-1 is latent shortly after infection |
| Q24563268 | Ability of the human cytomegalovirus IE1 protein to modulate sumoylation of PML correlates with its functional activities in transcriptional regulation and infectivity in cultured fibroblast cells |
| Q34998851 | Absence of IE1 p72 protein function during low-multiplicity infection by human cytomegalovirus results in a broad block to viral delayed-early gene expression |
| Q34701811 | Activating transcription factor 4 and X box binding protein 1 of Litopenaeus vannamei transcriptional regulated white spot syndrome virus genes Wsv023 and Wsv083. |
| Q37254205 | Activation of Langerhans-Type Dendritic Cells Alters Human Cytomegalovirus Infection and Reactivation in a Stimulus-Dependent Manner |
| Q39595937 | Activation of cJUN N-terminal kinase by herpes simplex virus type 1 enhances viral replication |
| Q39595998 | Activation of herpesvirus gene expression by the human cytomegalovirus protein pp71. |
| Q39722660 | Activation of stress-activated MAP protein kinases up-regulates expression of transgenes driven by the cytomegalovirus immediate/early promoter |
| Q37422869 | Activation of the NF-kappaB pathway in human cytomegalovirus-infected cells is necessary for efficient transactivation of the major immediate-early promoter |
| Q33841123 | Allogeneic transplantation induces expression of cytomegalovirus immediate-early genes in vivo: a model for reactivation from latency |
| Q40422902 | Analysis of proteins binding to the proximal promoter region of the human cytomegalovirus IE-1/2 enhancer/promoter reveals both consensus and aberrant recognition sequences for transcription factors Sp1 and CREB. |
| Q45861315 | Analysis of signal transduction pathways in macrophages using expression vectors with CMV promoters: a cautionary tale |
| Q40060615 | Antioxidants selectively suppress activation of NF-kappa B by human T-cell leukemia virus type I Tax protein |
| Q71814530 | Association between HIV and other DNA viruses in vitro |
| Q24670535 | Autorepression of the human cytomegalovirus major immediate-early promoter/enhancer at late times of infection is mediated by the recruitment of chromatin remodeling enzymes by IE86 |
| Q92809182 | Bright and Early: Inhibiting Human Cytomegalovirus by Targeting Major Immediate-Early Gene Expression or Protein Function |
| Q38300339 | CCAAT box-dependent activation of the TATA-less human DNA polymerase alpha promoter by the human cytomegalovirus 72-kilodalton major immediate-early protein |
| Q50609371 | CMV enhancer-promoter is preferentially active in exocrine cells in vivo. |
| Q39742087 | CXCL10 production from cytomegalovirus-stimulated microglia is regulated by both human and viral interleukin-10. |
| Q61800023 | Cell Type-Specific Roles of NF-κB Linking Inflammation and Thrombosis |
| Q39881018 | Cell and viral regulatory elements enhance the expression and function of a human immunodeficiency virus inhibitory gene |
| Q39281623 | Cell type-specific activation of the cytomegalovirus promoter by dimethylsulfoxide and 5-aza-2'-deoxycytidine |
| Q45859711 | Cellular oncogene activation by human cytomegalovirus Lack of correlation with virus infectivity and immediate early gene expression |
| Q36690707 | Characterization of human cytomegalovirus UL84 early gene and identification of its putative protein product |
| Q24645354 | Cloning and mutagenesis of a herpesvirus genome as an infectious bacterial artificial chromosome |
| Q37244905 | Comparative sequence analysis of human cytomegalovirus strains |
| Q35068584 | Constitutive and enhanced expression from the CMV major IE promoter in a defective adenovirus vector |
| Q55240430 | Constitutive expression of the HTLV-I pX and env regions in Jurkat T-cells induces differential activation of SRE, CRE and NF kappa B pathways. |
| Q39646686 | Control of cytomegalovirus lytic gene expression by histone acetylation |
| Q39448135 | Cytomegalovirus IE2 protein stimulates interleukin 1beta gene transcription via tethering to Spi-1/PU.1. |
| Q39812885 | Cytomegalovirus promoter up-regulation is the major cause of increased protein levels of unstable reporter proteins after treatment of living cells with proteasome inhibitors |
| Q35837092 | Cytomegalovirus-mediated induction of antisense mRNA expression to UL44 inhibits virus replication in an astrocytoma cell line: identification of an essential gene |
| Q33782001 | Defective growth correlates with reduced accumulation of a viral DNA replication protein after low-multiplicity infection by a human cytomegalovirus ie1 mutant |
| Q38876451 | Demonstration of Tightly Radiation-Controlled Molecular Switch Based on CArG Repeats by In Vivo Molecular Imaging. |
| Q35860583 | Developmental analysis of the cytomegalovirus enhancer in transgenic animals |
| Q38316296 | Direct interaction of the human cytomegalovirus IE86 protein with the cis repression signal does not preclude TBP from binding to the TATA box. |
| Q39026298 | Dynamics of unfolded protein response in recombinant CHO cells |
| Q33643399 | Effects of human cytomegalovirus major immediate-early proteins in controlling the cell cycle and inhibiting apoptosis: studies with ts13 cells |
| Q33957986 | Engagement of the cellular receptor for glycoprotein B of human cytomegalovirus activates the interferon-responsive pathway |
| Q37043521 | Engineering Periodic shRNA for Enhanced Silencing Efficacy |
| Q38335483 | Enhancement of RNA polymerase II initiation complexes by a novel DNA control domain downstream from the cap site of the cytomegalovirus major immediate-early promoter |
| Q38529528 | Erythropoietin enhancer stimulates production of a recombinant protein by Chinese hamster ovary (CHO) cells under hypoxic condition |
| Q38289804 | Expression of a constitutive NF-kappa B-like activity is essential for proliferation of cultured bovine vascular smooth muscle cells |
| Q39582163 | Extracellular signal-regulated kinase activity is sustained early during human cytomegalovirus infection |
| Q35770616 | Formation of several specific nucleoprotein complexes on the human cytomegalovirus immediate early enhancer |
| Q33701853 | HCMV IL-10 suppresses cytokine expression in monocytes through inhibition of nuclear factor-kappaB. |
| Q36698102 | Herpes simplex virus type 1-mediated induction of human immunodeficiency virus type 1 provirus correlates with binding of nuclear proteins to the NF-kappa B enhancer and leader sequence |
| Q38019133 | Histone deacetylases in viral infections |
| Q30503430 | Human cytomegalovirus (HCMV) immediate-early enhancer/promoter specificity during embryogenesis defines target tissues of congenital HCMV infection. |
| Q39872769 | Human cytomegalovirus IE1 and IE2 proteins block apoptosis |
| Q33886711 | Human cytomegalovirus IE1 protein elicits a type II interferon-like host cell response that depends on activated STAT1 but not interferon-γ |
| Q37030169 | Human cytomegalovirus IE1 protein enhances herpes simplex virus type 1-induced syncytial formation in U373MG cells |
| Q40048677 | Human cytomegalovirus IE86 protein interacts with promoter-bound TATA-binding protein via a specific region distinct from the autorepression domain |
| Q34858442 | Human cytomegalovirus activates inflammatory cytokine responses via CD14 and Toll-like receptor 2. |
| Q42424904 | Human cytomegalovirus attenuates interleukin-1beta and tumor necrosis factor alpha proinflammatory signaling by inhibition of NF-kappaB activation |
| Q39321145 | Human cytomegalovirus blocks tumor necrosis factor alpha- and interleukin-1beta-mediated NF-kappaB signaling |
| Q36680389 | Human cytomegalovirus ie2 negatively regulates alpha gene expression via a short target sequence near the transcription start site |
| Q39874785 | Human cytomegalovirus immediate-early 2 (IE2) protein can transactivate the human hsp70 promoter by alleviation of Dr1-mediated repression |
| Q36651434 | Human cytomegalovirus immediate-early gene 2 protein interacts with itself and with several novel cellular proteins |
| Q40584504 | Human cytomegalovirus stimulates cellular IKK2 activity and requires the enzyme for productive replication. |
| Q34422068 | Human cytomegalovirus tropism for mucosal myeloid dendritic cells |
| Q33842473 | Human cytomegalovirus up-regulates the phosphatidylinositol 3-kinase (PI3-K) pathway: inhibition of PI3-K activity inhibits viral replication and virus-induced signaling |
| Q35845633 | Human cytomegalovirus upregulates NF-kappa B activity by transactivating the NF-kappa B p105/p50 and p65 promoters |
| Q46723963 | Human cytomegalovirus-inhibitory flavonoids: studies on antiviral activity and mechanism of action |
| Q34510455 | Human herpesvirus 6 major immediate early promoter has strong activity in T cells and is useful for heterologous gene expression |
| Q36640831 | Human immunodeficiency viruses containing heterologous enhancer/promoters are replication competent and exhibit different lymphocyte tropisms |
| Q99726127 | Identification of Modulators of HIV-1 Proviral Transcription from a Library of FDA-Approved Pharmaceuticals |
| Q36640150 | Identification of a large bent DNA domain and binding sites for serum response factor adjacent to the NFI repeat cluster and enhancer region in the major IE94 promoter from simian cytomegalovirus. |
| Q41576192 | In vivo and in vitro analysis of transcriptional activation mediated by the human cytomegalovirus major immediate-early proteins. |
| Q33814326 | In vivo replication of recombinant murine cytomegalovirus driven by the paralogous major immediate-early promoter-enhancer of human cytomegalovirus |
| Q40727899 | Induction of the RelB NF-kappaB subunit by the cytomegalovirus IE1 protein is mediated via Jun kinase and c-Jun/Fra-2 AP-1 complexes |
| Q39879958 | Induction of the transcription factor Sp1 during human cytomegalovirus infection mediates upregulation of the p65 and p105/p50 NF-kappaB promoters |
| Q39512381 | Infection of endothelial cells with Trypanosoma cruzi activates NF-kappaB and induces vascular adhesion molecule expression. |
| Q38760428 | Inflammasome expression and cytomegalovirus viremia in critically ill patients with sepsis |
| Q35796129 | Infrequency of cytomegalovirus genome in coronary arteriopathy of human heart allografts |
| Q39599295 | Inhibition of the FACT Complex Reduces Transcription from the Human Cytomegalovirus Major Immediate Early Promoter in Models of Lytic and Latent Replication |
| Q53429002 | Initial transforming event in myelodysplastic syndromes may be viral: case for cytomegalovirus. |
| Q35837543 | Interactions between human immunodeficiency virus type 1 and human cytomegalovirus in human term syncytiotrophoblast cells coinfected with both viruses. |
| Q34676977 | Longitudinal, noninvasive imaging of T-cell effector function and proliferation in living subjects |
| Q35748464 | Metabotropic glutamate receptor-dependent long-term depression is impaired due to elevated ERK signaling in the ΔRG mouse model of tuberous sclerosis complex |
| Q36798296 | Modulation of T-cell activation through protein kinase C- or A-dependent signalling pathways synergistically increases human immunodeficiency virus long terminal repeat induction by cytomegalovirus immediate-early proteins |
| Q57009346 | Modulation of the NFκb Signalling Pathway by Human Cytomegalovirus |
| Q58734475 | Molecular Determinants and the Regulation of Human Cytomegalovirus Latency and Reactivation |
| Q34174972 | Molecular pathways in virus-induced cytokine production |
| Q36090467 | Multiple mechanisms are implicated in the regulation of NF-kappa B activity during human cytomegalovirus infection |
| Q35139535 | NF-kappaB and virus infection: who controls whom |
| Q36944091 | Neutrality of the canonical NF-kappaB-dependent pathway for human and murine cytomegalovirus transcription and replication in vitro |
| Q34793671 | New cell-signaling pathways for controlling cytomegalovirus replication |
| Q37948126 | OX40:OX40L axis: emerging targets for improving poxvirus-based CD8(+) T-cell vaccines against respiratory viruses |
| Q33783411 | Persistence and expression of the herpes simplex virus genome in the absence of immediate-early proteins |
| Q36806198 | Phytohemagglutinin-induced activity of cyclic AMP (cAMP) response elements from cytomegalovirus is reduced by cyclosporine and synergistically enhanced by cAMP |
| Q28193489 | Prolonged activation of NF-kappaB by human cytomegalovirus promotes efficient viral replication and late gene expression |
| Q90051675 | Pseudorabies virus infection of epithelial cells leads to persistent but aberrant activation of the NF-κB pathway, inhibiting hallmark NF-κB-induced pro-inflammatory gene expression |
| Q41504900 | Ras oncogene enhances the production of a recombinant protein regulated by the cytomegalovirus promoter in BHK-21 cells |
| Q33781921 | Reactivation of the previously silenced cytomegalovirus major immediate-early promoter in the mouse liver: involvement of NFkappaB. |
| Q24564855 | Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1 |
| Q38760564 | Regulation of the transcription and replication cycle of human cytomegalovirus is insensitive to genetic elimination of the cognate NF-kappaB binding sites in the enhancer |
| Q34364116 | RelB-p50 NF-kappa B complexes are selectively induced by cytomegalovirus immediate-early protein 1: differential regulation of Bcl-x(L) promoter activity by NF-kappa B family members |
| Q39881533 | Repression of gene expression upon infection of cells with herpes simplex virus type 1 mutants impaired for immediate-early protein synthesis. |
| Q33835064 | Repression of human cytomegalovirus major immediate early gene expression by the cellular transcription factor CCAAT displacement protein |
| Q37350384 | Rhinovirus stimulation of interleukin-6 in vivo and in vitro. Evidence for nuclear factor kappa B-dependent transcriptional activation |
| Q35551066 | Rickettsia rickettsii infection of cultured human endothelial cells induces NF-kappaB activation |
| Q37596556 | Role of the proximal enhancer of the major immediate-early promoter in human cytomegalovirus replication |
| Q27469944 | Salicylates inhibit flavivirus replication independently of blocking nuclear factor kappa B activation |
| Q38328767 | Simian virus 40 strains with novel properties generated by replacing the viral enhancer with synthetic oligonucleotides |
| Q35792192 | Specific History of Heterologous Virus Infections Determines Anti-Viral Immunity and Immunopathology in the Lung |
| Q40062240 | Strong trans activation of the human cytomegalovirus major immediate-early enhancer by p40tax of human T-cell leukemia virus type I via two repetitive tax-responsive sequence elements |
| Q40394584 | Structural and functional characterization of the promoter regions of the NFKB2 gene |
| Q35873576 | Synergistic interactions between overlapping binding sites for the serum response factor and ELK-1 proteins mediate both basal enhancement and phorbol ester responsiveness of primate cytomegalovirus major immediate-early promoters in monocyte and T- |
| Q36783447 | T-cell activation is required for efficient replication of human herpesvirus 6. |
| Q35894831 | TAF-like functions of human cytomegalovirus immediate-early proteins |
| Q40503318 | The 21 bp repeat element of the human cytomegalovirus major immediate early enhancer is a negative regulator of gene expression in undifferentiated cells |
| Q82858263 | The Elk-1 and serum response factor binding sites in the major immediate-early promoter of human cytomegalovirus are required for efficient viral replication in quiescent cells and compensate for inactivation of the NF-kappaB sites in proliferating |
| Q39604604 | The R3 region, one of three major repetitive regions of human herpesvirus 6, is a strong enhancer of immediate-early gene U95. |
| Q24300688 | The UL144 gene product of human cytomegalovirus activates NFkappaB via a TRAF6-dependent mechanism |
| Q58559675 | The Viral Tegument Protein pp65 Impairs Transcriptional Upregulation of IL-1β by Human Cytomegalovirus through Inhibition of NF-kB Activity |
| Q40727824 | The carboxyl-terminal region of human cytomegalovirus IE1491aa contains an acidic domain that plays a regulatory role and a chromatin-tethering domain that is dispensable during viral replication |
| Q35860573 | The enhancer domain of the human cytomegalovirus major immediate-early promoter determines cell type-specific expression in transgenic mice |
| Q36782726 | The human cytomegalovirus 2.7-kilobase RNA promoter contains a functional binding site for the adenovirus major late transcription factor |
| Q35872328 | The human cytomegalovirus IE1-72 protein interacts with the cellular p107 protein and relieves p107-mediated transcriptional repression of an E2F-responsive promoter. |
| Q35887796 | The human cytomegalovirus UL55 (gB) and UL75 (gH) glycoprotein ligands initiate the rapid activation of Sp1 and NF-kappaB during infection |
| Q37945177 | The human cytomegalovirus major immediate-early proteins as antagonists of intrinsic and innate antiviral host responses. |
| Q35857513 | The human cytomegalovirus virion possesses an activated casein kinase II that allows for the rapid phosphorylation of the inhibitor of NF-kappaB, IkappaBalpha |
| Q38334131 | The immunosuppressant FK-506 specifically inhibits mitogen-induced activation of the interleukin-2 promoter and the isolated enhancer elements NFIL-2A and NF-AT1 |
| Q38242199 | The intimate relationship between human cytomegalovirus and the dendritic cell lineage |
| Q46853154 | The intricate interplay between RNA viruses and NF-κB. |
| Q35878510 | The role of ATF in regulating the human cytomegalovirus DNA polymerase (UL54) promoter during viral infection. |
| Q35899034 | The role of Kupffer cell activation and viral gene expression in early liver toxicity after infusion of recombinant adenovirus vectors. |
| Q40400361 | The transcription factor YY1 binds to negative regulatory elements in the human cytomegalovirus major immediate early enhancer/promoter and mediates repression in non-permissive cells |
| Q42448429 | Thrombin induces Sp1-mediated antiviral effects in cytomegalovirus-infected human retinal pigment epithelial cells |
| Q36690662 | Transactivation of the cytomegalovirus ICP36 gene promoter requires the alpha gene product TRS1 in addition to IE1 and IE2 |
| Q40038595 | Transcriptional activation by the human cytomegalovirus immediate-early proteins: requirements for simple promoter structures and interactions with multiple components of the transcription complex. |
| Q40040068 | Tumor necrosis factor alpha promotes replication and pathogenicity of rat cytomegalovirus. |
| Q35866154 | Two distinct upstream regulatory domains containing multicopy cellular transcription factor binding sites provide basal repression and inducible enhancer characteristics to the immediate-early IES (US3) promoter from human cytomegalovirus |
| Q35847129 | UL82 virion protein activates expression of immediate early viral genes in human cytomegalovirus-infected cells |
| Q40812884 | Viral mediated redirection of NEMO/IKKγ to autophagosomes curtails the inflammatory cascade |
Search more.